Connection
Katja Kiseljak-Vassiliades to Drug Repositioning
This is a "connection" page, showing publications Katja Kiseljak-Vassiliades has written about Drug Repositioning.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.442 |
|
|
|
-
Subramanian C, McNamara K, Hess D, Croslow SW, Tan Y, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS. A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease. Surgery. 2026 Jan; 189:109702.
Score: 0.229
-
Subramanian C, McNamara K, Croslow SW, Tan Y, Hess D, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS. Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway. Surgery. 2025 01; 177:108832.
Score: 0.213